ArticleLangenbeck's archives of surgery2025
Application of indocyanine green fluorescence angiography in laparoscopic sleeve gastrectomy: preliminary results.
Article in Langenbeck's archives of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Challenges of Postoperative Tissue Flap Vitality Monitoring in Obese Individuals.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn recent years, as researchers have discovered that indocyanine green (ICG) near-infrared fluorescence imaging offers excellent tissue penetration, the application of ICG fluorescence angiography (ICG-FA) in various laparoscopic procedures has become increasingly widespread and gets significant therapeutic efficacy. However, its use in laparoscopic sleeve gastrectomy (LSG) has not been extensively reported. MATERIALS AND
methodsA retrospective study was conducted on the clinical data of 291 patients who underwent LSG at our clinical medical center between September 2021 and November 2024. The patients were divided into two groups: Group A, consisting of 195 cases (without intraoperative use of ICG-FA), and Group B, comprising 96 cases (with intraoperative use of ICG-FA). Statistical software was utilized for data processing and analysis.
resultsThe mean blood loss along the staple line was 6.53 ± 1.69 mL in Group A and 2.57 ± 1.81 mL in Group B (p < 0.001). The mean operative time was 99.01 ± 22.63 min in Group A and 94.04 ± 22.88 min in Group B (p < 0.05). The mean hospital stay was 5.89 ± 1.48 days in Group A and 4.95 ± 2.92 days in Group B (p < 0.001). Among all 291 patients, there were 2 cases of gastric leakage, with 1 case occurring in each group, 4 patients experienced postoperative bleeding, with 2 cases occurring in each group.
conclusionsFindings from our institutional data indicate that while ICG-FA demonstrated statistically significant reductions in staple line bleeding (due to suture needle punctures), shorter mean operative time, and decreased average hospital stay, its clinical benefits in LSG for morbid obesity appear limited compared to its established utility in other laparoscopic procedures. Furthermore, ICG-FA did not reduce the incidence of postoperative complications, such as gastric leaks or bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.